Phreesia, Inc. (PHR) Financial Ratio Screen

NYSE Healthcare United States USD 662M
RATIOS FAIL*
Automated financial screen · activity assessed separately
Phreesia, Inc. (PHR) is potentially non-compliant in the automated ratio model. Phreesia, Inc. operates in the Healthcare sector.

Track PHR screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

PHR financial screening at a glance

RATIOS FAIL*Financial ratios shown separately from business review — not a fatwa
Debt ratio
4.6%
Pass vs 30%
Cash ratio
21.7%
Pass vs 30%
Receivables + cash
40.6%
Fail vs 30%
Impermissible income
0.6%
Pass vs 5%

Calculation date: 2026-08-31. Financial period used: January 2025. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleFinancial criteria not metAt least one available ratio exceeds its threshold
FTSE/Yasaar-styleFinancial criteria passedActivity is assessed separately
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodJanuary 2025Calculation date2026-08-31S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Health Information Services) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from January 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 4.6%
/ 30%
21.7%
/ 30%
40.6%
/ 30%
0.64%
/ 5%
RATIOS FAIL*
FTSE 4.6%
/ 33%
21.7%
/ 33%
40.6%
/ 50%
0.64%
/ 5%
FINANCIAL SCREEN PASSED*

Financial Highlights

EPS
$-0.09
P/B Ratio
2.1
EV/EBITDA
16.3
EV: $235M
Revenue
$420M
Growth: 45.7%
Beta
0.7
Low volatility
Current Ratio
2.4

Profitability

Gross Margin 68.2%
Operating Margin -46.7%
Net Margin -1.2%
Return on Equity (ROE) -1.9%
Return on Assets (ROA) -0.3%

Cash Flow & Balance Sheet

Operating Cash Flow$32M
Free Cash Flow$8M
Total Debt$18M
Debt-to-Equity2.6
Current Ratio2.4
Total Assets$388M

Price & Trading

Last Close$11.65
50-Day MA$12.70
200-Day MA$21.00
Avg Volume1.6M
Beta0.7
52-Week Range
$10.75
$32.76

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-03-29 for the financial period January 2025. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About Phreesia, Inc. (PHR)

CEO
Mr. Chaim Indig
Employees
2,082
Sector
Healthcare
Industry
Health Information Services
Country
United States
Exchange
NYSE
Market Cap (listing currency)
USD 662M
Currency
USD

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is Phreesia, Inc. (PHR) halal to invest in?

The current automated result is Financial criteria not met or an activity exclusion was detected. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is Phreesia, Inc.'s debt ratio?

Phreesia, Inc.'s debt ratio is 4.6% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are Phreesia, Inc.'s key financial metrics?

Phreesia, Inc. has a market capitalization of USD 662M in its listing currency, and revenue of $420M. The company maintains a gross margin of 68.2% and a net margin of -1.2%. Return on equity stands at -1.9%.

How often is the screening data updated?

Calculation date: 2026-08-31. Financial period: January 2025. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.